Apellis Pharmaceuticals shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apellis Pharmaceuticals by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.8M | 124k | 22.63 |
| 2025-03-31 | $6.7M | 308k | 21.87 |
| 2024-12-31 | $7.8M | 243k | 31.91 |
| 2024-09-30 | $5.6M | 195k | 28.84 |
| 2024-06-30 | $5.6M | 147k | 38.36 |
| 2024-03-31 | $19M | 320k | 58.78 |
| 2023-12-31 | $19M | 311k | 59.86 |
| 2023-09-30 | $13M | 352k | 38.04 |
| 2023-06-30 | $62M | 682k | 91.10 |
| 2023-03-31 | $44M | 663k | 65.96 |
| 2022-12-31 | $56M | 1.1M | 51.71 |
| 2022-06-30 | $37M | 810k | 45.22 |
| 2022-03-31 | $25M | 500k | 50.81 |
| 2021-12-31 | $24M | 498k | 47.28 |
| 2021-09-30 | $34M | 1.0M | 32.96 |
| 2021-03-31 | $48M | 1.1M | 42.91 |
| 2020-12-31 | $62M | 1.1M | 57.20 |
| 2020-09-30 | $41M | 1.3M | 30.17 |
| 2020-06-30 | $34M | 1.0M | 32.66 |
| 2019-12-31 | $15M | 498k | 30.62 |
| 2019-09-30 | $8.8M | 365k | 24.09 |
| 2019-06-30 | $11M | 421k | 25.34 |
| 2019-03-31 | $3.9M | 198k | 19.53 |
| 2018-12-31 | $767k | 58k | 13.20 |
| 2018-09-30 | $1.3M | 73k | 17.78 |
| 2018-06-30 | $1.4M | 65k | 22.01 |